CeriBell, Inc (CBLL)vsMedtronic PLC (MDT)
CBLL
CeriBell, Inc
$23.63
+0.85%
HEALTHCARE · Cap: $906.87M
MDT
Medtronic PLC
$90.96
-0.72%
HEALTHCARE · Cap: $116.35B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 36719% more annual revenue ($37.54B vs $101.96M). MDT leads profitability with a 13.9% profit margin vs -64.7%. MDT earns a higher WallStSmart Score of 68/100 (B-).
CBLL
Avoid28
out of 100
Grade: F
MDT
Strong Buy68
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CBLL.
Margin of Safety
+3.7%
Fair Value
$94.43
Current Price
$90.96
$3.47 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 32.5% year-over-year
Conservative balance sheet, low leverage
Large-cap with strong market position
Reasonable price relative to book value
Earnings expanding 40.7% YoY
Generating 1.3B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -51.4% — below average capital efficiency
Expensive relative to growth rate
Grey zone — moderate risk
Comparative Analysis Report
WallStSmart ResearchBull Case : CBLL
The strongest argument for CBLL centers on Revenue Growth, Debt/Equity. Revenue growth of 32.5% demonstrates continued momentum.
Bull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, EPS Growth. Revenue growth of 13.7% demonstrates continued momentum.
Bear Case : CBLL
The primary concerns for CBLL are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : MDT
The primary concerns for MDT are PEG Ratio, Altman Z-Score.
Key Dynamics to Monitor
CBLL profiles as a hypergrowth stock while MDT is a value play — different risk/reward profiles.
CBLL is growing revenue faster at 32.5% — sustainability is the question.
MDT generates stronger free cash flow (1.3B), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MDT scores higher overall (68/100 vs 28/100) and 13.7% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CeriBell, Inc
HEALTHCARE · MEDICAL DEVICES · USA
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company is headquartered in Sunnyvale, California.
Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?